Symphogen A/s

Les Laboratoires Servier

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Thomas Bouquin

Mikkel Wandahl Pedersen

Michael Kragh

Gunther Roland Galler

Klaus Koefoed

Ivan David Horak

Torben Gjetting

Michael Monrad Grandal

Monika Gad

Camilla Fröhlich

Vikram Kjøller Bhatia

Johan Lantto

Helle Jane Jacobsen

Trine Lindsted

Thomas Tuxen Poulsen

Karsten Wessel Eriksen

Paolo Conrotto

Vikram Kjoller Bhatia

This invention relates to anti-PD-1 antibodies and methods of using them in treating diseases and conditions related to PD-1 activity, e.g., cancer.

Anti-PD-1 antibodies and compositions

This invention relates to anti-LAG-3 antibodies and methods of using them in treating diseases and conditions that benefit from modulating LAG-3 activity, e.g., cancer.

Anti-lag-3 antibodies and compositions

Anti-LAG-3 antibodies and compositions

This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer.

Anti-TIM-3 antibodies and compositions

This invention relates to anti-PD-1 antibodies and methods of using them in treating diseases and conditions related to PD-lactivity, e.g., cancer.

The present invention relates to novel recombinant antibodies directed against human MET (c-MET), as well as compositions comprising mixtures of at least two of said antibodies and use of the antibodies and antibody compositions for treatment of MET-mediated disorders such as cancer.

Anti-MET antibodies and compositions

Growing community of inventors

Alleroed, Denmark

Thomas Bouquin